Italy

“A. Menarini Diagnostics announces the release of the Prime-MDx platform”

FLORENCE, ITALY, May 22, 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated molecular diagnostics platform for the processing of various testing portfolios through real-time PCR.

WORLDLAB - EUROMEDLAB 2023

Rome, 21-25 May 2023

SATELLITE MEETING "POINT-OF-CARE TESTING: HOME, HOSPITAL AND BEYOND"

Rome, 20 - 21 May 2023

MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH’S AFIAS-10 SYSTEM

FLORENCE, ITALY, April 19ᵗʰ 2023, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others), building on several years of fruitful collaboration  with Boditech Med Inc. (Boditech)  in Italy. 

1345678910Last

Our values

10 core values have influenced the progress of our group.

READ MORE »